Font Size: a A A
Keyword [chronic myelogenous]
Result: 161 - 180 | Page: 9 of 10
161. The Mechanism Of MiR-409-3p On Suppressing Invasion And Metastases Of Gastric Cancer And The Role Of MiR-202 In Chemotherapy Sensitivity To CML
162. Serious Thrombocytopenia After Imatinib Treatment For CML-CP:A Case Report And Literature Review
163. Clinical Research Of Children With Chronic Myelogenous Leukemia Treated With Targeted Therapy
164. Discontinuation Of Tyrosine Kinase Inhibitors In Patients With Chronic Myeloid Leukemia:a Meta-Analysis
165. The Amplification Effect Of Microvesicles Produced By CML Cells On Myeloid-derived Suppressor Cells
166. Design, Synthesis And Evaluation Of Small Molecmle Drugs Against Chronic Myelogenous Leukemia
167. Study On Apoptosis Of Leukemia Cells Induced By Lycorine And The Caspase Pathway
168. The Role And Mechanism Of Exosomes In Imatinib Resistance Of Chronic Myelogenous Leukemia
169. One-step Discrimination Of BCR/ABLp210 Transcript Isoform With Fusion-triggered Rolling Circle Amplification
170. Resensitizing To Tyrosine Kinase Inhibitor By Inhibiting PFKFB3 In TKI Resistant Chronic Myelogenous Leukemia Cells
171. LncRNA Transcriptomics Analysis And Functional Study In Cml Multidrug-resistant Cells
172. The Effect Of Paeoniflorin On Reversing Multidrug Resistance Of Chronic Myelogenous Leukemia Adriamvcin-resistant K562/ADR Cells And Its Molecular Mechanism
173. Exploration Of NK Cells Function And Megakaryocytes-related Proteins In CML Patients With TKI-resistance
174. Effects Of Ros-autophagy Loop On Imatinib Resistance In Chronic Myeloid Leukemia
175. Comparison Of Clinical Effects And Adverse Reactions Between Domestic And Imported Imatinib In The Chronic Phase Of Chronic Myelogenous Leukemia
176. YTHDF2 Promotes The Growth Of Chronic Myelogenous Leukemia As An M6A Reader Protein
177. Prognostic Value Of BCR-ABL And Clinical Significance Of ABL Kinase Domain Mutation After TKIs
178. TRIB2 Knockdown As A Regulator Of Chemotherapy Resistance And Proliferation Via The ERK/STAT3 Signaling Pathway In Human Chronic Myelogenous Leukemia K562/ADM Cells
179. The Study Of TAL1 In IM-induced CML Cell Apoptosis And Erythroid Differentiation
180. SOS1 Regulates Imatinib-Sensitivity And –Resistance With BCR-ABL1-Independent And Its Molecular Mechanismin Chronic Myelogenous Leukemia(CLM)
  <<First  <Prev  Next>  Last>>  Jump to